Spontaneous Tumor Lysis Syndrome: Case Report from UMAE No.71 and Review of the Literature
DOI:
https://doi.org/10.14738/bjhr.1303.6882Abstract
Tumor lysis (TLS) is an oncologic emergency resulting from the massive release of intracellular metabolites after rapid tumor cell destruction. Although it usually occurs after cytotoxic chemotherapy, spontaneous TLS may develop before treatment, especially in high-grade hematologic malignancies such as Burkitt lymphoma. We report the case of a 42-year-old male patient with constitutional symptoms, progressive abdominal distension, dyspnea, bulky abdominal and retroperitoneal disease, and histopathological findings compatible with non-Hodgkin lymphoma. On initial hematologic evaluation, laboratory test showed acute kidney injury, severe hyperuricemia, hyperkalemia and hyperphosphatemia, consistent with TLS before chemotherapy. HIV infection was subsequently confirmed and bone marrow aspiration was compatible with Burkitt lymphoma/leukemia. Despite intravenous hydration, allopurinol, phosphate binders, and urgent hemodialysis, the patient developed refractory metabolic abnormalities. Following induction chemotherapy with HyperCVAD, TLS worsened, leading to severe hyperkalemia with a sinusoidal electrocardiographic pattern and death. Spontaneous TLS is a rare but life-threatening complication requiring early recognition, risk stratification, and prompt multidisciplinary management..
References
Russi Noguera JA, Trujillo Rincón JF. Síndrome de lisis tumoral espontáneo en paciente con diagnóstico de cáncer de colon metastásico. Rev Med. 2024;32(2):107-113. doi:10.18359/rmed.7193
Cordero Araya EA, Choque Núñez Y, Hernández Pereira A. Síndrome de lisis tumoral: generalidades. Rev Cienc Salud Integr Conoc. 2021;5(5):103-112. doi:10.34192/cienciaysalud.v5i5.353
Al-Abbadi M, Al Hadidi S. Tumor lysis syndrome: pathophysiology, risk factors, management strategies, and prognostic indicators. Jordanian American Physicians Alhamid N, Sabbagh B, Alsarraj A, Lerma E, Caza T, Workeneh B, et al. Pitfalls of current diagnostic criteria of tumor lysis syndrome. Kidney Blood Press Res. 2024;49:266–272. doi:10.1159/000538328 Academy Journal. 2023;(3):1-9.
Puri I, Sharma D, Gunturu KS, Ahmed AA. Diagnosis and management of tumor lysis syndrome. J Community Hosp Intern Med Perspect. 2020;10(3):269–272. doi:10.1080/20009666.2020.1761185
Khan FY, Yousef MF. Updates on the diagnosis and management of tumor lysis syndrome. Libyan Int J Oncol. 2023;2(2):34-44. Scholar Publishing
Vásquez-Revilla HR, Revilla-Rodríguez E, Domínguez-Castro E. Síndrome de lisis tumoral espontáneo en una paciente embarazada complicada con leucemia promielocítica aguda M3 ingresada a la unidad de cuidados intensivos. Med Crit. 2024;38(3):226-229. doi:10.35366/117789
Enríquez Enríquez MJ. Síndrome de lisis tumoral: artículo de revisión. Oncología (Ecuador). 2024;34(2):68-76. doi:10.33821/743.
Lupușoru G, Ailincăi I, Frățilă G, Ungureanu O, Andronesi A, Lupușoru M, et al. Tumor lysis syndrome: an endless challenge in onco-nephrology. Biomedicines. 2022;10(5):1012. doi:10.3390/biomedicines10051012
Gutiérrez-Aguirre CH, Castro-Gutiérrez PM, Contreras-Ruiz F, Colunga-Pedraza P, Jaime-Pérez JC, Gómez-Almaguer D. Síndrome de lisis tumoral espontánea. Rev Hematol Méx. 2020;21(3):172-178. doi:10.24245/rev_hematol.v21i3.4408
Abdel-Nabey M, Chaba A, Serre J, Lengliné E, Azoulay E, Darmon M, et al. Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy. Ann Intensive Care. 2022;12:15. doi:10.1186/s13613-022-00990-1.
Alhamid N, Sabbagh B, Alsarraj A, Lerma E, Caza T, Workeneh B, et al. Pitfalls of current diagnostic criteria of tumor lysis syndrome. Kidney Blood Press Res. 2024;49:266–272. doi:10.1159/000538328
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 British Journal of Healthcare and Medical Research

This work is licensed under a Creative Commons Attribution 4.0 International License.